Replies

In the General/Chat forum, on a thread titled Dr. David Martin: Almost 20 years ago the spike protein was known to be a bioweapon, DugwayDuke wrote:
Financial analyst David Martin misrepresents studies and patent applications to promote the baseless claim that SARS-CoV-2 was developed as a bioweapon
DETAILS
Misleading: Contrary to Martin’s claims, early research on coronaviruses didn’t involve modified viruses nor human experimentation apart from studies of infections with naturally-occurring human coronaviruses establishing that these viruses caused colds.
Factually inaccurate: Old patent applications for coronavirus vaccines and vectors cited by Martin are for animal coronaviruses. None of them is related to SARS-CoV-2 nor do they prove that the virus was developed as a bioweapon.
https://healthfeedback.org/claimreview/financial-analyst-david-martin-misrepresents-studies-patent-applications-promote-baseless-claim-sars-cov-2-developed-bioweapon/
BTW, ‘Dr’ Martin isn’t a physician, he’s a financial analyst.
You're still relying on the Deep State 'fact checker' Healthfeedback.org. If you look outside controlled media and just research the guy you can see he's so much more than a 'financial analyst.' Well you knew that, but you didn't want others to know that. Here's just two paragraphs of his bio.
https://expose-news.com/2024/03/17/20-years-ago-the-spike-protein-was-known/
As a former Assistant Professor at the University of Virginia’s School of Medicine, Dr. Martin founded the University’s first wholly-owned, for-profit, research and development and technology transfer corporation. Engaged in domestic and international technology transfer, clinical research, and financing, this company pioneered new techniques of innovation management that have become industry standards. In 1999, Dr. Martin was appointed by the Governor of the Commonwealth of Virginia to serve on the Joint Commission on Technology and Science and has served the General Assembly and Virginia’s Centre for Innovative Technology on numerous occasions.
Dr. Martin has publications in law, medicine, engineering, finance and education. He maintains active research in the fields of linguistic genomics and fractal financial risk modelling, as well as continuing his over 15 years of research in cellular membrane ionic signalling.